title: Hepatocellular carcinoma recurrence after treatment with direct-acting antivirals: First, do no harm by withdrawing treatment.
authors.affiliation: Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: htorres@mdanderson.org.
authors.forename: Harrys A
authors.initials: HA
authors.lastname: Torres
authors.affiliation: Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: Jean-Nicolas
authors.initials: JN
authors.lastname: Vauthey
authors.affiliation: Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: Minas Platon
authors.initials: MP
authors.lastname: Economides
authors.affiliation: Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: Parag
authors.initials: P
authors.lastname: Mahale
authors.affiliation: Department of Gastroentestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: Ahmed
authors.initials: A
authors.lastname: Kaseb
mesh_terms: D000998:Antiviral Agents; D006528:Carcinoma, Hepatocellular; D006801:Humans; D008113:Liver Neoplasms; D009364:Neoplasm Recurrence, Local; D028761:Withholding Treatment
chemical_list: D000998:Antiviral Agents